Nuevos betalactámicos. Revisión. New beta-lactams. Literature review

Authors

  • Juan Eloy Cruz Quesada Especialista de I Grado en Medicina Interna. Instructor. Hospital Docente Clínico Quirúrgico "León Cuervo Rubio". Pinar del Río.
  • Cándido Moisés Morales Rodríguez Especialista de II Grado en Medicina Interna. Profesor Asistente. Hospital Docente Clínico Quirúrgico "León Cuervo Rubio". Pinar del Río.
  • Rolando Páez Rodríguez Especialista de I Grado en Medicina Interna. Hospital Docente Clínico Quirúrgico "León Cuervo Rubio". Pinar del Río.

Abstract

Se realizó una revisión bibliográfica sobre betalactámicos, de uso poco frecuente, con el objetivo de ampliar los conocimientos al respecto; llegando a la conclusión de que estos fármacos son muy útiles para combatir las sepsis, ya sea de forma profiláctica, de la comunidad o intrahospitalaria. No obstante se debe hacer un uso correcto de los mismos para evitar el surgimiento de resistencia bacteriana, efectos indeseables, así como el aumento de costos hospitalarios.

DeCS: BETALACTAMICOS, CARBAPENEMICOS, CARBACEFEMICOS, MONOBACTAMICOS.

ABSTRACT

A bibliographic review about beta-lactams was made, they are seldom used it is aimed at widening the knowledge in this field, it is concluded that this drugs are very useful against sepsis, prophylacticaly in the community or intra-hospital. However, a correct use of these drugs must be made in order to avoid bacterial resistance, undesirable effects, as well as the increase of hospital costs.

DeCS: LACTAMIC ANTIBIOTICS/ drug effects.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Cruz Quesada JE, Morales Rodríguez CM, Páez Rodríguez R. Nuevos betalactámicos. Revisión. New beta-lactams. Literature review. Rev Ciencias Médicas [Internet]. 2012 Sep. 28 [cited 2025 Aug. 30];4(2):2-9. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/85

Issue

Vol. 4 No. 2 (2000)

Section

ORIGINAL ARTICLES

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/